#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3684	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2189	490.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1716	1716	T	523	T	430	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3684	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2189	490.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1450	1450	C	522	C	432	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5914	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	434.2	0	.	n	.	0	T695C	SNP	695	695	T	1291	1291	C	450	C,A	342,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5914	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	434.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2234	2234	G	510	G,A,T	410,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5914	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	434.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2567	2567	C	585	C,T	470,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5914	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	434.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2641	2641	A	599	A	476	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	5914	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4080	434.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3193	3193	C	518	C	424	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	482	folP	855	855	100.0	folP.l15.c4.ctg.1	1969	73.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1313	1315	AGC	100;101;101	A;G;C	77;77;75	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	1132	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3787	89.4	0	.	p	.	0	E915D	NONSYN	2743	2745	GAG	3256	3258	GAT	112;112;112	G;A;T	92;88;87	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	1132	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3787	89.4	1	SNP	p	S91F	1	.	.	271	273	TTC	784	786	TTC	117;115;116	T;T,G;C	92;87,1;89	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	1132	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3787	89.4	1	SNP	p	D95G	1	.	.	283	285	GGC	796	798	GGC	116;115;117	G;G;C	90;89;90	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	1132	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3787	89.4	1	SNP	p	G95N	0	.	.	283	285	GGC	796	798	GGC	116;115;117	G;G;C	90;89;90	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	539	488	mtrR	633	633	99.53	mtrR.l6.c4.ctg.1	1672	87.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	600	602	ACC	126;127;128	A;C;C	102;102;102	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	539	488	mtrR	633	633	99.53	mtrR.l6.c4.ctg.1	1672	87.6	1	SNP	p	G45D	1	.	.	133	135	GAC	618	620	GAC	128;128;128	G;A;C	102;101;100	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	288	mtrR_promoter	250	250	98.8	mtrR_promoter.l6.c4.ctg.1	1351	63.8	0	.	n	.	0	T10C	SNP	10	10	T	583	583	C	113	C	90	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	288	mtrR_promoter	250	250	98.8	mtrR_promoter.l6.c4.ctg.1	1351	63.8	0	.	n	.	0	G120A	SNP	120	120	G	693	693	A	112	A	94	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	288	mtrR_promoter	250	250	98.8	mtrR_promoter.l6.c4.ctg.1	1351	63.8	0	.	n	.	0	A197.	DEL	197	197	A	769	769	A	124	A	99	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1078	parC	2304	2304	99.65	parC.l6.c4.ctg.1	3384	95.2	0	.	p	.	0	E91G	NONSYN	271	273	GAG	849	851	GGG	106;106;106	G;G;G	93;91;91	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1078	parC	2304	2304	99.65	parC.l6.c4.ctg.1	3384	95.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1881	1883	GCA	111;111;111	G,T;C;A	94,1;95;94	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1078	parC	2304	2304	99.65	parC.l6.c4.ctg.1	3384	95.2	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2364	2366	ATT	109;110;111	A;T;T	91;89;91	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1078	parC	2304	2304	99.65	parC.l6.c4.ctg.1	3384	95.2	1	SNP	p	D86N	0	.	.	256	258	GAC	834	836	GAC	106;105;105	G;A,C;C	89;85,1;86	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1078	parC	2304	2304	99.65	parC.l6.c4.ctg.1	3384	95.2	1	SNP	p	S87I	0	.	.	259	261	AGT	837	839	AGT	105;105;105	A,G;G;T	83,1;89;86	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1078	parC	2304	2304	99.65	parC.l6.c4.ctg.1	3384	95.2	1	SNP	p	S87W	0	.	.	259	261	AGT	837	839	AGT	105;105;105	A,G;G;T	83,1;89;86	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1078	parC	2304	2304	99.65	parC.l6.c4.ctg.1	3384	95.2	1	SNP	p	S87R	0	.	.	259	261	AGT	837	839	AGT	105;105;105	A,G;G;T	83,1;89;86	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	1078	parC	2304	2304	99.65	parC.l6.c4.ctg.1	3384	95.2	1	SNP	p	S88P	0	.	.	262	264	TCC	840	842	TCC	105;105;105	T;C;C	86;91;89	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	978	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3083	95.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1796	1798	GGC	112;111;111	G;G;C,T	87;84;84,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1377	1379	GCA	137;138;138	G;C;A	108;107;111	penA.17.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1380	1382	ATC	138;138;138	A;T;C	110;107;112	penA.17.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1392	1394	GTG	134;133;132	G,T;T;G,A	108,1;106;104,1	penA.17.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1392	1394	GTG	134;133;132	G,T;T;G,A	108,1;106;104,1	penA.17.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1896	1898	ACC	100;101;101	A,C;C;C	78,1;89;88	penA.17.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1950	1952	GTG	101;102;104	G;T;G	84;72;74	penA.17.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1950	1952	GTG	101;102;104	G;T;G	84;72;74	penA.17.001:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2073	2075	AGC	105;103;105	A;G;C	79;79;82	penA.17.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2082	2084	GGC	107;107;106	G;G;C	84;82;82	penA.17.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.17.001	penA.17.001	1	1	27	938	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2705	103.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2100	2102	CCG	108;109;109	C,G;C;G	85,1;82;78	penA.17.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1228	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3433	107.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1823	1825	CCG	96;97;99	C;C;G	75;74;82	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	596	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2112	84.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	529	531	GGC	121;122;122	G;G;C	97;93;94	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	596	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2112	84.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	711	711	C	93	C	78	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	748	porB1b	1047	1047	99.52	porB1b.l6.c4.ctg.1	1854	119.0	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	761	763	AAG	166;165;165	A;A;G,A	134;131;134,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	748	porB1b	1047	1047	99.52	porB1b.l6.c4.ctg.1	1854	119.0	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1052	1054	GGT	153;153;153	G;G;T	125;125;123	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	748	porB1b	1047	1047	99.52	porB1b.l6.c4.ctg.1	1854	119.0	0	.	p	.	0	R257G	NONSYN	769	771	AGG	1172	1174	GGG	142;142;142	G;G;G	118;115;115	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	748	porB1b	1047	1047	99.52	porB1b.l6.c4.ctg.1	1854	119.0	1	SNP	p	A121D	1	.	.	361	363	GAC	764	766	GAC	164;162;162	G;A;C	134;133;133	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	748	porB1b	1047	1047	99.52	porB1b.l6.c4.ctg.1	1854	119.0	1	SNP	p	D121N	0	.	.	361	363	GAC	764	766	GAC	164;162;162	G;A;C	134;133;133	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2400	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5302	135.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2234	2236	CAT	120;120;120	C;A;T,G	98;99;100,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	382	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1338	85.3	1	SNP	p	V57M	1	.	.	169	171	ATG	636	638	ATG	153;153;152	A;T;G	131;126;124	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
